Synthesis and preliminary evaluation of 18F-labeled 1-(6,7-dimethyl-4-(methylamino)-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-2-(trans-2-(6-fluoropyridin-3-yl)cyclopropyl)ethan-1-one for imaging muscarinic acetylcholine receptor subtype 4

被引：1
|
作者：
Deng, Xiaoyun [1 ,2 ]
Zhang, Yiding [3 ]
Rong, Jian [1 ,2 ]
Kumata, Katsushi [3 ]
Shao, Tuo [1 ,2 ]
Wang, Gangqiang [4 ]
Hatori, Akiko [3 ]
Mori, Wakana [3 ]
Yu, Qingzhen [1 ,2 ]
Hu, Kuan [3 ]
Fujinaga, Masayuki [3 ]
Shao, Yihan [5 ]
Josephson, Lee [1 ,2 ]
Sun, Shaofa [4 ]
Zhang, Ming-Rong [3 ]
Liang, Steven [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St, Boston, MA 02114 USA
[2] Harvard Med Sch, 55 Fruit St, Boston, MA 02114 USA
[3] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiopharmaceut Dev, Chiba 2638555, Japan
[4] Hubei Univ Sci & Technol, Coll Nucl Technol & Chem & Biol, Hubei Collaborat Innovat Ctr Nonpower Nucl Techno, Xianning, Peoples R China
[5] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA
来源：
TETRAHEDRON LETTERS | 2020年 / 61卷 / 27期
基金：
美国国家卫生研究院;
关键词：
Muscarinic acetylcholine receptor subtype 4 (M-4); Fluorine; 18; Positron emission tomography (PET); Autoradiography; Alzheimer's disease; IDENTIFICATION; LOCALIZATION; XANOMELINE; DISCOVERY; AGONIST; DISEASE; BRAIN;
D O I：
10.1016/j.tetlet.2020.152060
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Positive allosteric modulators of muscarinic acetylcholine receptor subtype 4 have been identified as promising activators for the treatment of neurological disorders and neurodegenerative diseases, including schizophrenia, Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Herein we report the synthesis and preliminary evaluation of a F-18-labeled positron emission tomography ligand based on a M-4 activator (7). F-18-Isotopologue of 7 was prepared in a reasonable radiochemical yield with high radiochemical purity (>99%) and high molar activity (>37 GBq/mu mol). In vitro autoradiography studies indicated that the ligand possessed moderate in vitro specific binding. Dynamic PET studies in vivo demonstrated that [F-18]7 (also named as [1(8)F]M4R-1911) failed to cross the blood-brain barrier. Therefore, further chemical scaffold optimization in chemotype of 7 is necessary to overcome limited brain permeability and improve specific binding. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页数：6
相关论文
共 36 条
  • [1] Radiosynthesis and preliminary PET evaluation of 18F-labeled 2-(1-(3-fluorophenyl)-2-oxo-5-(pyrimidin-2-yl)-1,2-dihydropyridin-3-yl)benzonitrile for imaging AMPA receptors
    Yuan, Gengyang
    Jones, Graham B.
    Vasdev, Neil
    Liang, Steven H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4857 - 4860
  • [2] 1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition
    Shinde, Anil Karbhari
    Badange, Rajesh Kumar
    Reballi, Veena
    Achanta, Pramod Kumar
    Bojja, Kumar
    Manchineella, Sravanthi
    Muddana, Nageswara Rao
    Subramanian, Ramkumar
    Palacharla, Raghava Choudary
    Benade, Vijay
    Jayarajan, Pradeep
    Thentu, Jagadeesh Babu
    Lingavarapu, Bujji Babu
    Yarra, Sivasekhar
    Kagita, Narendra
    Doguparthi, Mallikarjuna Rao
    Mohammed, Abdul Rasheed
    Nirogi, Ramakrishna
    CHEMMEDCHEM, 2022, 17 (03)
  • [3] Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols
    Balfour, Michael N.
    Franco, Caio H.
    Moraes, Carolina B.
    Freitas-Junior, Lucio H.
    Stefani, Helio A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 128 : 202 - 212
  • [4] Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one
    Fujimoto, Takuya
    Tobisu, Mamoru
    Konishi, Noriko
    Kawamura, Masaki
    Tada, Norio
    Takagi, Terufumi
    Kubo, Keiji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (23) : 7993 - 8002
  • [5] Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor
    Swanson, Devin M.
    Savall, Brad M.
    Coe, Kevin J.
    Schoetens, Freddy
    Koudriakova, Tatiana
    Skaptason, Judith
    Wall, Jessica
    Rech, Jason
    Deng, Xiahou
    De Angelis, Meri
    Everson, Anita
    Lord, Brian
    Wang, Qi
    Ao, Hong
    Scott, Brian
    Sepassi, Kia
    Lovenberg, Timothy W.
    Carruthers, Nicholas I.
    Bhattacharya, Anindya
    Letavic, Michael A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8535 - 8548
  • [6] Radiosynthesis and evaluation of 4-(6-[18F]Fluoro-4-(5-isopropoxy-1H-indazol-3-yl)pyridin-2-yl)morpholine as a novel radiotracer candidate targeting leucine-rich repeat kinase 2
    Mori, Wakana
    Yamasaki, Tomoteru
    Hattori, Yasushi
    Zhang, Yiding
    Kumata, Katsushi
    Fujinaga, Masayuki
    Hanyu, Masayuki
    Nengaki, Nobuki
    Zhang, Hong
    Zhang, Ming-Rong
    RSC MEDICINAL CHEMISTRY, 2020, 11 (06): : 676 - 684
  • [7] A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)
    Johnson, Christopher N.
    Ahn, Jong Sook
    Buck, Ildiko M.
    Chiarparin, Elisabetta
    Day, James E. H.
    Hopkins, Anna
    Howard, Steven
    Lewis, Edward J.
    Martins, Vanessa
    Millemaggi, Alessia
    Munck, Joanne M.
    Page, Lee W.
    Peakman, Torren
    Reader, Michael
    Rich, Sharna J.
    Saxty, Gordon
    Smyth, Tomoko
    Thompson, Neil T.
    Ward, George A.
    Williams, Pamela A.
    Wilsher, Nicola E.
    Chessari, Gianni
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 7314 - 7329
  • [8] Synthesis and evaluation of 5,7-dihydro-3-[2-[1-(4-[18F] fluorobenzyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]1,2-benzisoxazol-6-one for in vivo mapping of acetylcholinesterase
    Lee, SY
    Choe, YS
    Kim, YR
    Paik, JY
    Choi, BW
    Kim, SE
    Lee, KH
    Choi, Y
    Kim, BT
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (06) : 591 - 596
  • [9] Synthesis and evaluation of 6-[1-(2-[18F]fluoro-3-pyridyl)-5-methyl-1H-1,2,3-triazol-4-yl]quinoline for positron emission tomography imaging of the metabotropic glutamate receptor type 1 in brain
    Fujinaga, Masayuki
    Yamasaki, Tomoteru
    Kawamura, Kazunori
    Kumata, Katsushi
    Hatori, Akiko
    Yui, Joji
    Yanamoto, Kazuhiko
    Yoshida, Yuichiro
    Ogawa, Masanao
    Nengaki, Nobuki
    Maeda, Jun
    Fukumura, Toshimitsu
    Zhang, Ming-Rong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) : 102 - 110
  • [10] Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase
    Hattori, Yasushi
    Aoyama, Kazunobu
    Maeda, Jun
    Arimura, Naoto
    Takahashi, Yasuko
    Sasaki, Masako
    Fujinaga, Masayuki
    Seki, Chie
    Nagai, Yuji
    Kawamura, Kazunori
    Yamasaki, Tomoteru
    Zhang, Ming-Rong
    Higuchi, Makoto
    Koike, Tatsuki
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2362 - 2375
1234